12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Adagio: Phase I/II data

Preliminary data from the Phase I/II Samba 01 trial in 12 Type I diabetics showed that Adagio was safe and well tolerated and did not lead to coughing. Dance Biopharm...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >